HEADER STRUCTURAL GENOMICS, ISOMERASE 10-JAN-02 1KS2 TITLE CRYSTAL STRUCTURE ANALYSIS OF THE RPIA, STRUCTURAL GENOMICS, PROTEIN TITLE 2 EC1268. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN EC1268, RPIA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RPIA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS STRUCTURAL GENOMICS, ISOMERASE, PSI, PROTEIN STRUCTURE INITIATIVE, KEYWDS 2 MIDWEST CENTER FOR STRUCTURAL GENOMICS, MCSG EXPDTA X-RAY DIFFRACTION AUTHOR R.ZHANG,A.JOACHIMIAK,A.M.EDWARDS,T.SKARINA,A.SAVCHENKO,MIDWEST CENTER AUTHOR 2 FOR STRUCTURAL GENOMICS (MCSG) REVDAT 7 20-NOV-24 1KS2 1 SEQADV LINK REVDAT 6 11-OCT-17 1KS2 1 REMARK REVDAT 5 24-FEB-09 1KS2 1 VERSN REVDAT 4 04-DEC-07 1KS2 1 AUTHOR REVDAT 3 29-MAR-05 1KS2 1 AUTHOR JRNL REMARK REVDAT 2 18-JAN-05 1KS2 1 AUTHOR KEYWDS REMARK REVDAT 1 14-AUG-02 1KS2 0 JRNL AUTH R.ZHANG,C.E.ANDERSSON,A.SAVCHENKO,T.SKARINA,E.EVDOKIMOVA, JRNL AUTH 2 S.BEASLEY,C.H.ARROWSMITH,A.M.EDWARDS,A.JOACHIMIAK, JRNL AUTH 3 S.L.MOWBRAY JRNL TITL STRUCTURE OF ESCHERICHIA COLI RIBOSE-5-PHOSPHATE ISOMERASE: JRNL TITL 2 A UBIQUITOUS ENZYME OF THE PENTOSE PHOSPHATE PATHWAY AND THE JRNL TITL 3 CALVIN CYCLE. JRNL REF STRUCTURE V. 11 31 2003 JRNL REFN ISSN 0969-2126 JRNL PMID 12517338 JRNL DOI 10.1016/S0969-2126(02)00933-4 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1047468.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 62538 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 5874 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 18013 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 901 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.009 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3190 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.24000 REMARK 3 B22 (A**2) : -1.97000 REMARK 3 B33 (A**2) : 1.73000 REMARK 3 B12 (A**2) : -0.56000 REMARK 3 B13 (A**2) : -0.67000 REMARK 3 B23 (A**2) : -0.78000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.11 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.11 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 50.71 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-02. REMARK 100 THE DEPOSITION ID IS D_1000015282. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795, 0.9798,0.94656 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62538 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 40.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.90 REMARK 200 R MERGE FOR SHELL (I) : 0.19700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.95 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: APC065 RELATED DB: TARGETDB DBREF 1KS2 A 1 219 UNP P0A7Z0 RPIA_ECOLI 1 219 DBREF 1KS2 B 1 219 UNP P0A7Z0 RPIA_ECOLI 1 219 SEQADV 1KS2 MSE A 42 UNP P0A7Z0 MET 42 MODIFIED RESIDUE SEQADV 1KS2 MSE A 90 UNP P0A7Z0 MET 90 MODIFIED RESIDUE SEQADV 1KS2 MSE A 92 UNP P0A7Z0 MET 92 MODIFIED RESIDUE SEQADV 1KS2 MSE A 138 UNP P0A7Z0 MET 138 MODIFIED RESIDUE SEQADV 1KS2 MSE A 174 UNP P0A7Z0 MET 174 MODIFIED RESIDUE SEQADV 1KS2 MSE A 182 UNP P0A7Z0 MET 182 MODIFIED RESIDUE SEQADV 1KS2 MSE B 42 UNP P0A7Z0 MET 42 MODIFIED RESIDUE SEQADV 1KS2 MSE B 90 UNP P0A7Z0 MET 90 MODIFIED RESIDUE SEQADV 1KS2 MSE B 92 UNP P0A7Z0 MET 92 MODIFIED RESIDUE SEQADV 1KS2 MSE B 138 UNP P0A7Z0 MET 138 MODIFIED RESIDUE SEQADV 1KS2 MSE B 174 UNP P0A7Z0 MET 174 MODIFIED RESIDUE SEQADV 1KS2 MSE B 182 UNP P0A7Z0 MET 182 MODIFIED RESIDUE SEQRES 1 A 219 MET THR GLN ASP GLU LEU LYS LYS ALA VAL GLY TRP ALA SEQRES 2 A 219 ALA LEU GLN TYR VAL GLN PRO GLY THR ILE VAL GLY VAL SEQRES 3 A 219 GLY THR GLY SER THR ALA ALA HIS PHE ILE ASP ALA LEU SEQRES 4 A 219 GLY THR MSE LYS GLY GLN ILE GLU GLY ALA VAL SER SER SEQRES 5 A 219 SER ASP ALA SER THR GLU LYS LEU LYS SER LEU GLY ILE SEQRES 6 A 219 HIS VAL PHE ASP LEU ASN GLU VAL ASP SER LEU GLY ILE SEQRES 7 A 219 TYR VAL ASP GLY ALA ASP GLU ILE ASN GLY HIS MSE GLN SEQRES 8 A 219 MSE ILE LYS GLY GLY GLY ALA ALA LEU THR ARG GLU LYS SEQRES 9 A 219 ILE ILE ALA SER VAL ALA GLU LYS PHE ILE CYS ILE ALA SEQRES 10 A 219 ASP ALA SER LYS GLN VAL ASP ILE LEU GLY LYS PHE PRO SEQRES 11 A 219 LEU PRO VAL GLU VAL ILE PRO MSE ALA ARG SER ALA VAL SEQRES 12 A 219 ALA ARG GLN LEU VAL LYS LEU GLY GLY ARG PRO GLU TYR SEQRES 13 A 219 ARG GLN GLY VAL VAL THR ASP ASN GLY ASN VAL ILE LEU SEQRES 14 A 219 ASP VAL HIS GLY MSE GLU ILE LEU ASP PRO ILE ALA MSE SEQRES 15 A 219 GLU ASN ALA ILE ASN ALA ILE PRO GLY VAL VAL THR VAL SEQRES 16 A 219 GLY LEU PHE ALA ASN ARG GLY ALA ASP VAL ALA LEU ILE SEQRES 17 A 219 GLY THR PRO ASP GLY VAL LYS THR ILE VAL LYS SEQRES 1 B 219 MET THR GLN ASP GLU LEU LYS LYS ALA VAL GLY TRP ALA SEQRES 2 B 219 ALA LEU GLN TYR VAL GLN PRO GLY THR ILE VAL GLY VAL SEQRES 3 B 219 GLY THR GLY SER THR ALA ALA HIS PHE ILE ASP ALA LEU SEQRES 4 B 219 GLY THR MSE LYS GLY GLN ILE GLU GLY ALA VAL SER SER SEQRES 5 B 219 SER ASP ALA SER THR GLU LYS LEU LYS SER LEU GLY ILE SEQRES 6 B 219 HIS VAL PHE ASP LEU ASN GLU VAL ASP SER LEU GLY ILE SEQRES 7 B 219 TYR VAL ASP GLY ALA ASP GLU ILE ASN GLY HIS MSE GLN SEQRES 8 B 219 MSE ILE LYS GLY GLY GLY ALA ALA LEU THR ARG GLU LYS SEQRES 9 B 219 ILE ILE ALA SER VAL ALA GLU LYS PHE ILE CYS ILE ALA SEQRES 10 B 219 ASP ALA SER LYS GLN VAL ASP ILE LEU GLY LYS PHE PRO SEQRES 11 B 219 LEU PRO VAL GLU VAL ILE PRO MSE ALA ARG SER ALA VAL SEQRES 12 B 219 ALA ARG GLN LEU VAL LYS LEU GLY GLY ARG PRO GLU TYR SEQRES 13 B 219 ARG GLN GLY VAL VAL THR ASP ASN GLY ASN VAL ILE LEU SEQRES 14 B 219 ASP VAL HIS GLY MSE GLU ILE LEU ASP PRO ILE ALA MSE SEQRES 15 B 219 GLU ASN ALA ILE ASN ALA ILE PRO GLY VAL VAL THR VAL SEQRES 16 B 219 GLY LEU PHE ALA ASN ARG GLY ALA ASP VAL ALA LEU ILE SEQRES 17 B 219 GLY THR PRO ASP GLY VAL LYS THR ILE VAL LYS MODRES 1KS2 MSE A 42 MET SELENOMETHIONINE MODRES 1KS2 MSE A 90 MET SELENOMETHIONINE MODRES 1KS2 MSE A 92 MET SELENOMETHIONINE MODRES 1KS2 MSE A 138 MET SELENOMETHIONINE MODRES 1KS2 MSE A 174 MET SELENOMETHIONINE MODRES 1KS2 MSE A 182 MET SELENOMETHIONINE MODRES 1KS2 MSE B 42 MET SELENOMETHIONINE MODRES 1KS2 MSE B 90 MET SELENOMETHIONINE MODRES 1KS2 MSE B 92 MET SELENOMETHIONINE MODRES 1KS2 MSE B 138 MET SELENOMETHIONINE MODRES 1KS2 MSE B 174 MET SELENOMETHIONINE MODRES 1KS2 MSE B 182 MET SELENOMETHIONINE HET MSE A 42 8 HET MSE A 90 8 HET MSE A 92 8 HET MSE A 138 8 HET MSE A 174 8 HET MSE A 182 8 HET MSE B 42 8 HET MSE B 90 8 HET MSE B 92 8 HET MSE B 138 8 HET MSE B 174 8 HET MSE B 182 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 HOH *660(H2 O) HELIX 1 1 GLN A 3 ALA A 14 1 12 HELIX 2 2 LEU A 15 VAL A 18 5 4 HELIX 3 3 GLY A 29 THR A 41 1 13 HELIX 4 4 SER A 53 LEU A 63 1 11 HELIX 5 5 ASP A 69 VAL A 73 5 5 HELIX 6 6 ALA A 99 VAL A 109 1 11 HELIX 7 7 ASP A 118 GLN A 122 5 5 HELIX 8 8 ALA A 139 LEU A 150 1 12 HELIX 9 9 ASP A 178 ALA A 188 1 11 HELIX 10 10 THR B 2 ALA B 14 1 13 HELIX 11 11 LEU B 15 VAL B 18 5 4 HELIX 12 12 GLY B 29 THR B 41 1 13 HELIX 13 13 MSE B 42 ILE B 46 5 5 HELIX 14 14 SER B 53 LEU B 63 1 11 HELIX 15 15 ASP B 69 VAL B 73 5 5 HELIX 16 16 ALA B 99 VAL B 109 1 11 HELIX 17 17 SER B 120 GLN B 122 5 3 HELIX 18 18 ALA B 139 LEU B 150 1 12 HELIX 19 19 ASP B 178 ALA B 188 1 11 SHEET 1 A 6 GLY A 48 SER A 51 0 SHEET 2 A 6 ILE A 23 VAL A 26 1 N VAL A 26 O VAL A 50 SHEET 3 A 6 LEU A 76 ASP A 81 1 O ILE A 78 N GLY A 25 SHEET 4 A 6 ALA A 110 CYS A 115 1 O ILE A 114 N TYR A 79 SHEET 5 A 6 VAL A 205 THR A 210 1 O VAL A 205 N CYS A 115 SHEET 6 A 6 GLY A 213 VAL A 218 -1 O LYS A 215 N ILE A 208 SHEET 1 B 3 GLU A 85 ILE A 86 0 SHEET 2 B 3 MSE A 92 ILE A 93 -1 O ILE A 93 N GLU A 85 SHEET 3 B 3 LEU A 197 PHE A 198 -1 O PHE A 198 N MSE A 92 SHEET 1 C 4 ARG A 153 TYR A 156 0 SHEET 2 C 4 VAL A 167 HIS A 172 -1 O HIS A 172 N ARG A 153 SHEET 3 C 4 LEU A 131 VAL A 135 -1 N VAL A 135 O VAL A 167 SHEET 4 C 4 VAL A 192 VAL A 195 -1 O VAL A 193 N GLU A 134 SHEET 1 D 6 GLY B 48 SER B 51 0 SHEET 2 D 6 ILE B 23 VAL B 26 1 N VAL B 26 O VAL B 50 SHEET 3 D 6 LEU B 76 ASP B 81 1 O VAL B 80 N GLY B 25 SHEET 4 D 6 ALA B 110 ASP B 118 1 O ILE B 114 N TYR B 79 SHEET 5 D 6 VAL B 205 THR B 210 1 O LEU B 207 N CYS B 115 SHEET 6 D 6 GLY B 213 VAL B 218 -1 O ILE B 217 N ALA B 206 SHEET 1 E 3 GLU B 85 ILE B 86 0 SHEET 2 E 3 MSE B 92 ILE B 93 -1 O ILE B 93 N GLU B 85 SHEET 3 E 3 LEU B 197 PHE B 198 -1 O PHE B 198 N MSE B 92 SHEET 1 F 4 ARG B 153 TYR B 156 0 SHEET 2 F 4 VAL B 167 HIS B 172 -1 O ASP B 170 N GLU B 155 SHEET 3 F 4 LEU B 131 VAL B 135 -1 N VAL B 135 O VAL B 167 SHEET 4 F 4 VAL B 192 VAL B 195 -1 O VAL B 193 N GLU B 134 LINK C THR A 41 N MSE A 42 1555 1555 1.33 LINK C MSE A 42 N LYS A 43 1555 1555 1.33 LINK C HIS A 89 N MSE A 90 1555 1555 1.33 LINK C MSE A 90 N GLN A 91 1555 1555 1.33 LINK C GLN A 91 N MSE A 92 1555 1555 1.33 LINK C MSE A 92 N ILE A 93 1555 1555 1.33 LINK C PRO A 137 N MSE A 138 1555 1555 1.33 LINK C MSE A 138 N ALA A 139 1555 1555 1.33 LINK C GLY A 173 N MSE A 174 1555 1555 1.33 LINK C MSE A 174 N GLU A 175 1555 1555 1.33 LINK C ALA A 181 N MSE A 182 1555 1555 1.33 LINK C MSE A 182 N GLU A 183 1555 1555 1.33 LINK C THR B 41 N MSE B 42 1555 1555 1.33 LINK C MSE B 42 N LYS B 43 1555 1555 1.33 LINK C HIS B 89 N MSE B 90 1555 1555 1.33 LINK C MSE B 90 N GLN B 91 1555 1555 1.33 LINK C GLN B 91 N MSE B 92 1555 1555 1.33 LINK C MSE B 92 N ILE B 93 1555 1555 1.33 LINK C PRO B 137 N MSE B 138 1555 1555 1.33 LINK C MSE B 138 N ALA B 139 1555 1555 1.33 LINK C GLY B 173 N MSE B 174 1555 1555 1.33 LINK C MSE B 174 N GLU B 175 1555 1555 1.33 LINK C ALA B 181 N MSE B 182 1555 1555 1.33 LINK C MSE B 182 N GLU B 183 1555 1555 1.33 CRYST1 42.119 42.120 59.429 89.94 100.95 98.73 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023742 0.003645 0.004700 0.00000 SCALE2 0.000000 0.024020 0.000689 0.00000 SCALE3 0.000000 0.000000 0.017146 0.00000